Add time:07/24/2019 Source:sciencedirect.com
This preliminary study has analyzed the potential ability of the 5-HT1A ligand SPIROXATRINE (cas 1054-88-2) to interact with vascular α1-adrenoceptors. Norepinephrine and the selective α1-adrenoceptor agonist, methoxamine, elicited concentration-dependent contractions of rat aortic rings. In contrast, (±)-spiroxatrine (from 10−8 to 3.1×10−7 M) was devoid of any effect on vascular tone per se, but shifted the concentration-response curves of norepinephrine and methoxamine to the right in a concentration-dependent manner with pA2 values of 8.48±0.22 and 8.93±0.33, respectively. Endothelium removal did not significantly affect the above pA2 values of (±)-spiroxatrine. These data, taken in concert, support the contention that (±)-spiroxatrine displays α1-adrenoceptor blocking properties in rat aortic rings.
We also recommend Trading Suppliers and Manufacturers of SPIROXATRINE (cas 1054-88-2). Pls Click Website Link as below: cas 1054-88-2 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View